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A family of cystein proteases, the caspases, plays a central role in mediating cell death. In this study, we measured the activation of the
initiator and effector caspase in real time, and studied the relationship between caspase activity and mitochondrial membrane potential in
living cells by means of bioimaging. We also designed and developed a fluorescence resonance energy transfer (FRET)-based genetically
encoded fluorescent indicator, which consisted of yellow fluorescent protein (YFP), a peptide sequence which can be cleaved by specific
caspases, and cyan fluorescent protein (CFP). Two peptide sequences which could be cleaved by initiator caspases and effector caspases,
respectively, were used. Simultaneous real-time measurements of the caspase activity and mitochondrial membrane potential in the cells
treated with TNF-a and staurosporine revealed that dying cells showed caspase activation and mitochondrial depolarization, and that these
events, however, were not firmly linked. Although it takes anywhere from 1 to over 10 h after the addition of the cell death inducer for the
caspases to begin to be activated, initiator caspases and effector caspases are activated within a short period of time at the last stage in the
entire process leading to cell death.
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1. Introduction tein, which is processed to its matured form and exerts itsApoptosis is an essential process for excluding damaged
or harmful cells and maintaining homeostasis in biological
systems. The disruption of this process is assumed to cause
various diseases, including cancer, autoimmune diseases,
and neurodegenerative diseases. Apoptosis can be induced
experimentally by such stimuli as UV irradiation, growth
factor withdrawal, death receptor ligands, or cytotoxic
drugs. These factors induce cell death via a cascade of
protease activation. These proteases are cystein proteases
called caspases. They play a central role in the apoptotic cell
death machinery [1,2]. Caspases are synthesized as propro-0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: kawai@nihs.go.jp (H. Kawai).catalytic activity at the proper time. For a better understand-
ing of cell death and the diseases that result from it, it is
important to elucidate the mechanism of caspase activation.
The caspases are divided into two groups, initiator
caspases (e.g., caspase-8, -9, -10) and effector caspases
(e.g., caspase-3, -6, -7). The initiator caspases act at an
earlier stage of cell death, and activate the effector caspases
by hydrolytic cleavage [3–9]. The effector caspases cleave
various substrates such as lamin, poly(ADP-ribose)polymer-
ase (PARP), and DNA fragmentation factor (DFF), which
cause biochemical and morphological changes in cells, and
finally bring about cell death [10,11]. For example, tumor
necrosis factor (TNF)-a, a well-known apoptosis inducer,
activates caspase-8 through signal transduction via the TNF
receptor, which is one of the death receptors [3–7,12].
Caspase-8 then cleaves and activates caspase-3, which
cleaves various substrates and causes apoptotic cell death.
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exert their activity without binding to the death receptor.
Mitochondria play a pivotal role in this pathway [8,9,13].
Mitochondrial membranes are affected by the cell death
signal, and cytochrome c (cyt. c) and other apoptosis-related
factors are released to cytosol. Cyt. c forms a protein
complex called apoptosome with Apaf-1 and procaspase-
9. Procaspase-9 is processed and activated in apoptosome,
and active caspase-9 cleaves caspase-3 to its active form.
Previous studies have identified various caspases and
revealed their roles in cell death machinery. But how each
reaction proceeds, and how these reactions relate to other
cellular events during cell death in living cells, has not been
thoroughly investigated.
Green fluorescent protein (GFP) and its variants are
widely used in biological studies [14]. They are used not
only as a fluorescent tag to visualize a certain protein, but
also to monitor the dynamic changes of intracellular sig-
nals, e.g., Ca2 +, IP3, protein kinase activities, and proteol-
ysis [15–26]. Some of these biological studies used the
fluorescent resonance energy transfer (FRET) between cyan
fluorescent protein (CFP) and yellow fluorescent protein
(YFP) [27]. CFP and YFP were linked with a small peptide
and/or functional protein(s), which changed their confor-
mation by means of a certain cellular signal. This confor-
mational change affected the FRET efficiency of the probe,
because FRET efficiency relates to the distance and angle
between two fluorophores. Since the FRET efficiency can
be estimated by the fluorescence ratio of YFP and CFP
(YFP/CFP), the change in the intracellular signal can be
detected by measuring the CFP and YFP fluorescence.
Bioimaging with a fluorescent probe and fluorescence
microscopy makes it possible to detect very subtle and
rapid signals in living cells, which is otherwise impossible,
and to reveal the temporal and spatial relationships between
these signals.
Several groups have already developed probes for
caspase activity and have monitored the caspase activities
in single cells [28–34]. Almost all of these researchers,
however, studied only effector caspase or caspase-3. In this
study, we tried to monitor the activity of initiator and
effector caspases by means of real-time bioimaging, and
investigated the relationship among the caspase activation,
mitochondrial membrane potential, and morphological
changes during cell death. Recently, Ohnuki et al. [32]
reported a fluorescent probe for caspase-8, and studied the
relationship between caspase-8 activation and h-amyloid
toxicity. Takemoto et al. [33] and Luo et al. [34] developed
a fluorescent probe for caspase-9 and caspase-8, and
carried out real-time imaging. We used a strategy similar
to theirs to develop the probe, but our report is the first to
show the relationship between initiator caspase activation
and mitochondrial depolarization. Because both of these
events are important in cell death machinery, clarifying
their temporal relationship by simultaneous imaging is a
significant step.2. Materials and methods
2.1. Plasmid construction
Plasmid encoding YFP-CFP was generated by PCR
with pECFP-C1 and pEYFP-C1 (Clontech, Palo Alto,
CA). The sequence encoding 11 amino acids at the C-
terminus of YFP was eliminated in this construct. The
linker connecting YFP and CFP was identical with the
multi cloning site of pEYFP-C1. This construct was cloned
in the NheI–NotI site of pEGFP-N1 vector. The oligonu-
cleotides encoding the respective caspase’s substrate se-
quence were inserted into the BspEI–AgeI site, and the
oligonucleotide encoding His10 followed by a stop codon
(TAA) was inserted into the BsrGI–NotI site at the C-
terminus of CFP. One caspase substrate sequence was
derived from procaspase-3 (5V-CCGGACTGGACTGTGG-
CATTGAGACAGACAGTGGTGTTGATGAA-3V and 5V-
CCGGTTCATCAACACCACTGTCTGTCTCAATGCCA-
CAGTCCAGT-3V), and another was derived from PARP
(5V-CCGGAAAGAGAAAAGGCGATGAGGTGGATG-
GAGTGGATGAA-3V and 5V-CCGGTTCATCCACTC-
CATCCACCTCATCGCCTTTTCTCTTT-3V) [35,36]. The
His10 sequence was made from the following oligonu-
c leo t ides , 5V-GTACAAGCACCACCACCACCA-
CCACCACCACCACCACTAAAGC - 3 Va n d 5 V-
GGCCGCTTTAGTGGTGGTGGTGGTGGTGGTGGTG-
GTGGTGCTT-3V. The amino acid sequences between
YFP and CFP are shown in Fig. 1. Oligonucleotides were
provided by Hokkaido System Science Co. (Sapporo,
Japan). All cloned sequences were verified by sequencing.
2.2. Cell culture and transfection
HeLa cells were cultured in DMEM (Sigma-Aldrich, St.
Louis, MO) supplemented with 100 units/ml of penicillin G,
100 Ag/ml of streptomycin and 10% fetal calf serum
(GIBCO). Plasmid encoding the fusion protein was trans-
fected into HeLa cells using Effectene Transfection Reagent
(QIAGEN, Hilden, Germany) according to the manufactur-
er’s instructions. After 12–24-h incubation with the trans-
fection reagent, the cells were washed with PBS and
cultivated on dishes suitable for assay in medium containing
500 Ag/ml of G418 for an additional 1–3 days until the
assay was performed.
2.3. Extraction and purification of the fusion proteins
Cells expressing the fusion protein were cultured in 60-
mm plastic dishes. The cells were washed with PBS and
lysed with 20 mM Tris–HCl buffer (pH 7.9) containing
0.5 M NaCl, 5 mM imidazole and 1% Triton X-100. The
lysate was centrifuged at 10,000 g for 10 min at 4 jC
and filtered with a 0.45-Am filter. The fusion protein that
contained His10 was purified with His-Bind Resin (Nova-
gen, Madison, WI) by following the manufacturer’s
Fig. 1. The probe protein consists of YFP, a substrate peptide of caspase, and CFP. When excited at 433 nm (excitation max. of CFP), this fusion protein shows
FRET and emits fluorescence at 527 nm (emission max. of YFP) if the protein is intact. If there are active caspases, the fusion proteins are cleaved, FRET does
not occur, and this fusion protein emits fluorescence at 475 nm (emission max. of CFP). The emission ratio of YFP/CFP indicates the caspase activity around
the probe protein. The linker region between YFP and CFP consists of 18 amino acids. The sequences derived from procaspase-3 (IC-sensor) and PARP (EC-
sensor) are underlined, and the site of consensus recognition by [the] caspase are shown in bold face.
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imidazole solution instead of 60 mM imidazole solution to
wash the resin after loading the sample. Purified fusion
proteins were obtained in 20 mM Tris–HCl buffer (pH 7.9)
containing 0.5 M NaCl and 1 M imidazole. The solvent
was changed to other buffers by centrifugation tube with a
MW 30,000 cutoff filter (Millipore, Bedford, MA) if
necessary.
2.4. Western blotting
Cells cultured in a plastic dish were washed with PBS
and lysed with 1 SDS loading buffer, or extracted protein
sample was mixed with the same amount of 2 SDS
loading buffer. The samples dissolved in 1 SDS loading
buffer were incubated at 95 jC for 2 min, and then they
were loaded onto SDS-polyacrylamide gels (10%). Proteins
were separated at 20 mA and then blotted to PVDF
membranes in Tris–glycine transfer buffer at 100 V for
2 h. The membrane was incubated with block ace (Dainip-
pon Pharmaceutical, Osaka, Japan) for 1 h, anti-GFP mono-
clonal antibody (Clontech, diluted with 0.1 block ace to
1:10,000) for 1–2 h, and anti-mouse IgG horseradish
peroxidase-conjugated secondary antibody (Chemicon In-
ternational Inc., Temecula, CA, diluted with 0.1 block ace
to 1:10,000) for 1 h. The membrane was washed with TBS-
T two to three times for 5 min after the incubation with the
antibody. All of these incubations were performed at room
temperature. The membrane was developed with the ECL
chemiluminescence detection reagent (Amersham Bioscien-
ces, Piscataway, NJ).
2.5. Measurement of fluorescence
The fluorescence of the fusion protein purified by His-
Bind Resin was measured using a HITACHI F-310 fluo-
rometer. Fluorescent spectra were scanned from 450 to
550 nm with a scanning speed of 120 nm/min after
excitation at 433 nm by Hg lamp.2.6. Cleavage of the fusion proteins by active caspases
Recombinant human active caspase-1 through caspase-
10 were purchased from BioVision (Mountain View, CA).
The purified fusion protein dissolved in 1 Reaction
Buffer (BioVision) was incubated with 1 unit of the respec-
tive active caspase at 37 jC for 1 h. One unit of the active
caspase is the enzyme activity that cleaves 1 nmol of the
individual substrate (YVAD-pNA for 1, VDVAD-pNA for
2, DEVD-pNA for 3 and 7, WEHD-pNA for 4 and 5, VEID-
pNA for 6, IETD-pNA for 8 and 10, and LEHD-pNA for 9),
per hour at 37 jC. Reactions were terminated by adding 2
SDS loading buffer and subjected to SDS-PAGE and
Western blotting.
2.7. Bioimaging with fluorescent microscopy
Transfected cells were cultured on a cover glass (25-mm
diameter, 0.15–0.18-mm thickness) for 1–3 days. Cells
were treated with TNF-a (200 ng/ml, dissolved in PBS)
or staurosporine (3 AM, dissolved in DMSO), and then
incubated under the usual culture condition for 1–2 h before
analysis. Tetramethylrhodamine methyl ester (TMRM,
50 nM, dissolved in DMSO) was added 20–30 min before
the analysis if mitochondrial membrane potential was to be
measured. Analyses were carried out by confocal laser
scanning fluorescent microscopy using a Carl Zeiss
LSM510 system. During the observation, the media were
buffered with 10 mM HEPES buffer (pH 7.4) and the cells
were maintained at 35–37 jC. DIC images and grayscale
images for fluorescence channels were obtained every 2 min
unless otherwise described. Excitation lights for the FRET
probe (458 nm) and TMRM (543 nm) were provided by an
Ar laser with a 458 dichroic mirror and a HeNe laser with a
543 dichroic mirror, respectively. Images of the FRET probe
were obtained separately for both cyan and yellow fluores-
cence using a 515 dichroic mirror and a BP467.5–497.5
emission filter for the cyan and a BP515–545 emission filter
for the yellow. Images of TMRM were obtained using a
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and a LP515 filter, which were loaded as a standard set in
LSM510, for cyan and yellow fluorescence, respectively,
but this setting was not suitable for our experiments for
several reasons. First, the cyan fluorescence obtained
through the BP475–515 filter was too weak, and second
the LP515 filter cannot exclude the possibility that TMRM-
derived fluorescence contaminated the channel for yellow
fluorescence. We prepared several emission filters, and
obtained the best results using the setting described above.
Contamination of the fluorescence between the channels
was negligible in this condition (data not shown). Images
were processed and quantified using MetaFluor software.
The fluorescent intensity of the whole cell area was used in
this analysis. As cells changed their morphology during the
observation, the whole cell areas were determined separately
in each image.Fig. 3. The fluorescent changes by the cell death stimuli. HeLa cells
expressing the IC-sensor or EC-sensor were incubated in the presence or
absence of 200 ng/ml of TNF-a for 6 h. The probe protein was extracted
and purified as described in Section 2, and the fluorescent spectra with
excitation at 433 nm were measured. The fluorescent spectra of the IC-
sensor (a) and EC-sensor (b) from non-treated cells (solid line) and TNF-a-
treated cells (dotted line) are shown.3. Results
3.1. Design of the probes
We designed and developed a FRET-based genetically
encoded fluorescent indicator, which consisted of YFP, a
peptide sequence which can be cleaved by specific caspases,
and CFP. Since FRET efficiency depends on the distance
between CFP and YFP, this fusion protein should show
FRET, which can be significantly reduced when the peptide
sequence is cleaved by active caspases (Fig. 1). We used
two peptide sequences, which were 12 amino acids in length
and contained a caspase recognition site in the middle. One
was derived from procaspase-3, and was expected to beFig. 2. Expression and cleavage of the probe proteins in HeLa cells. HeLa
cells transfected with plasmid encoding IC-sensor (lanes 3–5) or EC-sensor
(lanes 6–8) were exposed with 200 ng/ml of TNF-a (lanes 4 and 7) or 3
AM of staurosporine (lanes 5 and 8) for 6 h. The cell lysate of each
experiment was prepared and analyzed by Western blot analysis with anti-
GFP monoclonal antibody. A control experiment (non-transfected, non-
treated HeLa cells, lane 2) shows no band. Lane 1 shows recombinant GFP
as a reference. The arrow and arrowheads indicate intact and cleaved YFP-
peptide-CFP, respectively.cleaved by caspase-8/9/10, and the other was from PARP,
and was expected to be cleaved by caspase-3/6/7. These
probes, which we named the initiator caspase (IC)-sensor
and effector caspase (EC)-sensor, were able to indicate the
cleavage of procaspase-3 and PARP; in other words, they
were able to indicate the protease activities of the initiator
caspases and effector caspases, respectively.
3.2. Characterization of the probe proteins in living cells
HeLa cells expressing one of the probe proteins were
treated with a cell death inducer, consisting of either 200 ng/
ml of TNF-a or 3 AM of staurosporine. After 6 h of
exposure, the cells were lysed and underwent Western blot
analysis. As shown in Fig. 2, both probe proteins were
detected from the transfected HeLa cells (lanes 3–8), and
the 25–30-kDa fragments were detected from the cells
treated with TNF-a (lanes 4 and 7) or staurosporine (lanes
5 and 8). These fragments were identical to the cleaved
fragments (YFP-cleaved peptide and cleaved peptide-CFP-
His10). Both the IC-sensor and EC-sensor are successfully
expressed in HeLa cells, and are cleaved in cells by cell
death stimuli.
The fluorescent spectra of the probe proteins were
measured after purification with a His tag. Fig. 3 shows
the fluorescent spectra of the IC-sensor (a) and EC-sensor
(b) from the TNF-a-treated and non-treated (control) HeLa
cells expressing one of the probe proteins. The probe
proteins from the control cells showed spectra with two
emission peaks at 475 and 527 nm by excitation at 433 nm
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to those of CFP and YFP, respectively. The probe protein
from the TNF-a-treated cells also showed spectra with two
peaks, but compared with the non-treated control, the
emission at 475 nm was enhanced, and that at 527 nm
was reduced (dotted line in Fig. 3(a) and (b)). This result is
likely due to the cleavage of the probe protein by caspases,
which reduce the energy transfer from CFP to YFP. The
ratio of the emission intensity (527/475 nm) was reduced by
about 20–40% by the TNF-a treatment in this assay. The
staurosporine treatment produced the same results as the
TNF-a treatment (data not shown).
YFP can be excited directly by excitation light at 433 nm,
and, therefore, YFP fluorescence itself is not an indicator for
FRET. We measured the fluorescent ratio, and showed that
the ratio was reduced by cell death stimuli, indicating that
FRET from CFP to YFP was reduced. The fluorescent ratio
can be an indicator for FRET, and the reduction of the ratio
indicates the activation of the caspases. We used the
fluorescent ratio as the indicator for caspase activation in
the following experiments.
3.3. Cleavage of the fusion protein by recombinant caspase
In a cell-free system, we investigated which caspase
could cleave IC- and EC-sensors to confirm the specificity
of the probe proteins. The probe protein purified from a
HeLa cell lysate was incubated with human recombinant
caspase-1–10, and Western blotting with an anti-GFP
antibody was used to confirm whether the probe protein
was cleaved by the respective caspases. Fig. 4 shows the
results. The IC-sensor was cleaved by caspase-8 and cas-Fig. 4. Selective cleavage of the probe proteins by certain caspases. The
probe protein was incubated with recombinant active caspase-1–10 at 37 C
for 1 h. The resultants were analyzed by Western blotting with anti-GFP
monoclonal antibody. (A) IC-sensor; (B) EC-sensor. Numbers 1–10
represent the results from assays with caspase-1–10, respectively, and c
represents the control experiment in which the assay was performed in the
absence of caspase. The arrow and arrowheads indicate intact and cleaved
sensor proteins, respectively.pase-9, and slightly by caspase-5 and caspase-6. The bands
for the cleaved probe proteins were quantified, and the
activities of caspase-8 and -9 were estimated to be 5–10
times higher than that of caspase-5 and -6. The EC-sensor
was cleaved by caspase-3, and slightly by caspase-7, -8, and
-9. The caspase-3 activity was more than 10 times higher
than the activity of the other caspases. Although we cannot
exclude the possibility that some caspases can cleave the
probes in living cells despite their inability to cleave them in
this cell-free system, or that some proteases other than
caspase-1–10 can cleave them, these results clearly showed
that the IC- and EC-sensor proteins could mainly detect the
caspase-8/9 activity and caspase-3 activity, respectively.
3.4. Simultaneous bioimaging of caspase activity and
mitochondrial membrane potential
Next, we tried to carry out real-time detection of the
caspase activity and mitochondrial membrane potential in
single living cells. HeLa cells were transfected with the
caspase-sensor and treated with 50 nM of TMRM, a
mitochondrial membrane potential-indicator. It has been
reported that TMRM is less toxic than tetramethylrhod-
amine ethyl ester, and does not inhibit mitochondrial
respiration at this dose [37]. The caspase activity and
mitochondrial membrane potential were simultaneously
measured in living cells every 2 min by confocal laser-
scanning fluorescent microscopy, as described in Section 2.
A control study in which the cells were treated with solvent
(DMSO, 1%) did not show any fluorescent or morpholog-
ical changes (data not shown).
Fig. 5 shows typical images of the assay. Cells express-
ing the IC-sensor were treated with 200 ng/ml of TNF-a (a)
or 3 AM of staurosporine (b). After 1–6-h exposure,
changes were observed in some cells. The fluorescence of
the CFP channel increased, while that of the YFP channel
decreased (not shown in Fig. 5; see Fig. 6), and the emission
ratio of YFP/CFP, which represents the FRET efficiency,
dramatically decreased, indicating that the caspases were
activated. The fluorescence of TMRM also decreased,
indicating that the mitochondrial membrane potential was
reduced. As previously reported by other groups, the timing
of the response differs in each cell [28–30,33,34]. Since
several reports suggested that the induction of apoptosis is
related to the cell cycle, the difference of timing we
observed here might depend on which cell-cycle phase the
individual cells were in [38,39].
3.5. Morphology during cell death induced by TNF-a or
staurosporine
There were differences in morphology between the TNF-
a-treated and staurosporine-treated cells. The TNF-a-treated
cells shrank drastically when the caspase was activated,
whereas the staurosporine-treated cells did not show such
obvious changes in morphology, although the caspases were
Fig. 5. Time lapse images of the caspase activity and the mitochondrial membrane potential obtained by LSM510. HeLa cells expressing the IC-sensor were
incubated with 200 ng/ml of TNF-a (a) or 3 AM of staurosporine (b). The cells were then observed by confocal microscopy, and DIC and fluorescent images
were obtained at 2-min intervals, as described in Section 2. DIC images (upper panels), the emission ratio of YFP/CFP (middle panels), and the fluorescent
intensity of TMRM (lower panels) at the indicated time are shown in pseudo colors. The reduction of the YFP/CFP ratio represents caspase activation, and the
reduction of TMRM fluorescence represents the reduction of the mitochondrial membrane potential. The bars in the upper right images indicate 10 Am.
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Fig. 6. Fluorescent changes during cell death. HeLa cells expressing the IC-sensor (A, C) or EC-sensor (B, D, E, F) were incubated with 200 ng/ml of TNF-a
(A, B) or 3 AM of staurosporine (C, D, E, F). Fluorescent images as shown in Fig. 5 were obtained from each experiment, and then the YFP/CFP ratio and the
fluorescence of CFP, YFP, and TMRM for the whole single cell area were quantified and plotted. A–D each show a representative example of each treatment.
Filled square (cyan): CFP; filled diamond (yellow): YFP; open triangle: ratio (YFP/CFP);  : TMRM (red). The vertical axes show the mean pixel intensity of
the whole cell region (left; CFP, YFP, and TMRM) and the mean pixel emission ratio of the whole cell region (right; YFP/CFP ratio). a.u., arbitrary units.
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duced, just as in the TNF-a-treated cells (Fig. 5). The
temporal relationship between the caspase activation and
the morphological changes probably differs in these two
treatments. We speculated that other factor(s) are necessary
for the morphological changes during cell death to occur,
and that these factors are activated almost simultaneously
with the caspase in TNF-a-treated cells, whereas it takes
time to activate them after the caspase activation in staur-
osporine-treated cells.
3.6. Temporal relationship of caspase activation and
mitochondrial depolarization
Fig. 6(A)–(D) shows typical examples of the fluores-
cent changes that occurred in each treatment. The fluo-rescent intensity of the caspase-sensor and TMRM, and
the ratio of the YFP and CFP fluorescence of the caspase-
sensor were plotted. The horizontal axes indicate the time
after the cell death-inducer treatment. Each graph
shows the results from a respective single cell. (A) and
(C) show the results from cell #1 in Fig. 5(a) and (b),
respectively. The emission ratio of YFP/CFP was dramat-
ically reduced, indicating that the caspase was activated at
this point in that cell. The fluorescence intensity of
TMRM was reduced, indicating that the mitochondria
depolarized at this point in that cell. Fig. 6(E) and (F)
shows examples with a large time difference between the
caspase activation and the mitochondrial depolarization.
Caspase activation was observed 44 min earlier than the
mitochondrial depolarization in the cell shown in Fig.
6(E), whereas caspase activation was observed 42 min
Fig. 7. The time intervals between mitochondrial depolarization and caspase
activation. (a) We defined the difference between the two time points
indicated by the arrow and arrowhead as the time interval. Details are
described in the text. (b) We calculated and plotted this parameter for each
cell. Each plot represents one cell. The vertical lines, crosses, and bars
represent the median, mean, and 95% confidence interval for each group.
The number of cells used in each analysis is shown in parenthesis. Filled
mark (A, B): TNF-a; open mark (C, D): staurosporine; triangle (A, C): IC-
sensor; circle (B, D): EC-sensor.
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shown in Fig. 6(F).
The YFP emission should have decreased with the
caspase activation in ideal FRET system. However, the
YFP emission remained constant or increased in some cases
(Fig. 6). We considered this to have occurred because the
cells shrank immediately after caspase activation, especially
in the TNF-a-induced cell death, as shown in Fig. 5. This
caused the concentration of the fluorescent protein in the
cell, resulting in an increase of the CFP and YFP signals in
the confocal slice. This concentration effect was cancelled
out by ratiometric analysis. YFP showed unexpected fluo-
rescent changes in some cases, but we were able to evaluate
the FRET change properly by analyzing the fluorescent ratio
of YFP and CFP.
Sensor proteins were transiently transfected, and the
concentration of the sensor proteins was shown to be
different in each cell. Some cells expressed a high level of
sensor proteins and showed bright fluorescence, and other
cells expressed a low level of sensor proteins and showed
dim fluorescence. However, we found that the expression
level of the sensor proteins did not affect the slope of the
ratio trace.
In order to study the temporal relationship between the
caspase activation and the mitochondrial depolarization, we
carried out a quantitative analysis and estimated the relative
timing of the initiator- and effector-caspase activation and
mitochondrial depolarization. The starting point of the
reduction of the YFP/CFP ratio (A, indicated by an arrow
in Fig. 7(a)) and that of the TMRM fluorescence (B,
indicated by an arrowhead in Fig. 7(a)) were determined
as the time point after which the value decreased during four
continuous points or more, the value decreased more than
20% in total, and the reduction of the value was the last one
in the experiment. We determined these points in each cell,
and calculated the time interval from B to A. We analyzed
31–47 cells in at least seven independent experiments for
each treatment, and plotted the results in Fig. 7(b). Here,
each plot represents the result from a cell, with time 0 being
the point at which the TMRM fluorescence started to
decrease. If the plot is on  10, for example, this means
that the caspase activation occurred 10 min earlier than the
mitochondrial depolarization in that cell. This analysis
clarified the temporal relationship between mitochondrial
depolarization, initiator caspase activation, and effector
caspase activation.
Although Fig. 7 shows some scatter, which suggest that
the relationship between caspase activation and mitochon-
drial depolarization is not firm, we can estimate the rela-
tionship between the two by quantitative analysis. A trend
was seen in which the median values and mean values of the
time interval were estimated to be nearly 0 in all treatments.
This means that the caspase activation and mitochondrial
depolarization are likely to start within a short amount of
time in the majority of cells, compared with the duration
from drug treatment to these events, which takes anywherefrom 1 to over 10 h. Because initiator caspases are proteases
that cleave and activate effector caspases, the initiator
caspase might be activated earlier than the effector caspase.
Our results suggest that the effector caspase activation
occurred immediately after the initiator caspase activation.4. Discussion
In this study, we described a method for measuring
changes in the initiator or effector caspase activity and
mitochondrial membrane potential simultaneously in single
living cells in real time by means of bioimaging, which
revealed the kinetics of the caspase activation and the
relationship among the caspase activities, mitochondrial
membrane potential, and morphological changes during cell
death. The time schedule of cell death is different in each
cell, but dying cells show caspase activation and a reduction
of the mitochondrial membrane potential. In a dying cell, it
takes a long time, 1–10 h or more, from the addition of cell
death-inducers to start initiator caspase activation, and it
takes a relatively short time from the initiator caspase
activation to start effector caspase activation. This finding
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amount of time at the last stage in the entire biochemical
process leading to cell death.
Luo et al. [34] reported that the activation of caspase-
8 occurred much earlier than that of caspase-3 in TNF-a-
induced apoptosis. They calculated the time difference
between these activations as about 120 min on average,
which differed from ours. They measured the timing of the
caspase activation by comparing it with the timing of the
morphological change, which is very difficult to determine.
In our experiments, we compared the timing of the caspase
activation with that of mitochondrial depolarization, which
is much easier to analyze objectively, especially in the case
of staurosporine-induced cell death, which showed little
morphological change (Fig. 5). Therefore, we feel that our
conclusion is more reliable.
It is widely accepted that TNF-a brings about cell death
via binding with its receptor, receptor trimerization, binding
of the intracellular domain of the receptor with adaptor
proteins, cleavage (activation) of the initiator caspase (cas-
pase-8), and cleavage (activation) of the effector caspase
(caspase-3) [1]. In this study, we investigated the time
course of this pathway, and revealed that it takes a long
time after drug treatment, more than 10 h in some cases, to
start caspase activation. We speculate that this is a period in
which initiator caspase activation is prepared for. There are
likely some unknown factors which are essential to activat-
ing the initiator caspases. These factors delay the cell death
process and they determine the timing of cell death. Once
these events occur, the activation of caspases and further cell
death processes may proceed immediately.
The wide distribution of the plots in Fig. 7 suggests that
caspase activation and mitochondrial depolarization are not
firmly linked. Some cells showed mitochondrial depolariza-
tion earlier than caspase activation, and the other cells
showed mitochondrial depolarization later than caspase
activation, suggesting that these two events are indepen-
dently induced in cell death machinery. When cell death is
induced via mitochondrial change, cyt. c is released from
the mitochondria to the cytosol, which is a critical event for
cell death [1,8,9]. Cyt. c release leads caspase activation by
the formation of apoptosome in the cytosol. Both caspase
activation and mitochondrial depolarization relate to mito-
chondrial change, so these reactions occur within a short
amount of time in the majority of cells. But these reactions
occur with a large time interval in some cells because their
relationship is indirect and not rigid. The time schedule of
the process leading to each event may respectively depend
on individual cellular conditions. Luetjens et al. [40] have
reported on the mode of cyt. c release, and showed that cyt.
c was released within 10 min in the majority of cells,
whereas cyt. c was released stepwise with an intermediate
plateau about 30 min in duration in 13% of the release
events they observed. In some cells, a certain amount of cyt.
c was released from the mitochondria to cytosol, which was
enough to cause the apoptosome formation and the follow-ing caspase activation, but not enough to cause the mito-
chondrial depolarization because the cyt. c remaining in the
mitochondria can maintain the membrane potential. Early
caspase activation and late mitochondrial depolarization
would be observed in this case.
Cyt. c release and mitochondrial depolarization have
been analyzed using GFP-tagged cyt. c and potentiometric
dye such as TMRM [41]. It is likely that mitochondrial
depolarization is not required and is not sufficient for cyt. c
release [42], but the temporal relationship between cyt. c
release and depolarization is still controversial. Some
researchers have showed that cyt. c was released a long
time before mitochondrial depolarization [43,44], whereas
others have reported that cyt. c release followed mitochon-
drial depolarization [45]. The timing of mitochondrial
depolarization seems to depend on various factors, including
the cell death stimulant, cell type, and individual cell
condition. The relationship between caspase activation and
mitochondrial changes (cyt. c release, depolarization) needs
to be studied further.Acknowledgements
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